EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microglia and macrophages in glioblastoma: landscapes and treatment directions

Georgios Solomou, Adam M H Young, Harry J C J Bulstrode iD

Molecular Oncology · 2024-12 · 18 (12) · 2906-2926

DOI: 10.1002/1878-0261.13657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 07.05.2024. Verfasst von Georgios Solomou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, UK. Hauptthemen laut MEDLINE: Glioblastoma, Microglia, Macrophages, Brain Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most common primary malignant tumour of the central nervous system and remains uniformly and rapidly fatal. The tumour‐associated macrophage (TAM) compartment comprises brain‐resident microglia and bone marrow‐derived macrophages (BMDMs) recruited from the periphery. Immune‐suppressive and tumour‐supportive TAM cell states predominate in glioblastoma, and immunotherapies, which have achieved striking success in other solid tumours have consistently failed to improve survival in this ‘immune‐cold’ niche context. Hypoxic and necrotic regions in the tumour core are found to enrich, especially in anti‐inflammatory and immune‐suppressive TAM cell states. Microglia predominate at the invasive tumour margin and express pro‐inflammatory and interferon TAM cell signatures. Depletion of TAMs, or repolarisation towards a pro‐inflammatory state, are appealing therapeutic strategies and will depend on effective understanding and classification of TAM cell ontogeny and state based on new single‐cell and spatial multi‐omic in situ profiling. Here, we explore the application of these datasets to expand and refine TAM characterisation, to inform improved modelling approaches, and ultimately underpin the effective manipulation of function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicrogliaMacrophagesBrain NeoplasmsHumansAnimalsTumor MicroenvironmentTumor-Associated MacrophagesImmunotherapy

Stichwörter der Autor:innen

glioblastomagliomaimmunemacrophagesmicroenvironmentmicroglia

Autor:innen und Institutionen

  • Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, UK.
  • Department of Neurosurgery, Addenbrooke's Hospital, Cambridge, UK.

ORCID-Profile: Harry J C J Bulstrode

Förderung

  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Solomou, G., Young, A. M. H., & Bulstrode, H. J. C. J. (2024). Microglia and macrophages in glioblastoma: landscapes and treatment directions. Molecular Oncology, 18(12), 2906-2926. https://doi.org/10.1002/1878-0261.13657

Vancouver

Solomou G, Young AMH, Bulstrode HJCJ. Microglia and macrophages in glioblastoma: landscapes and treatment directions. Molecular Oncology. 2024;18(12):2906-2926. doi:10.1002/1878-0261.13657

BibTeX
@article{Solomou2024,
  author = {Solomou, Georgios and Young, Adam M H and Bulstrode, Harry J C J},
  title = {Microglia and macrophages in glioblastoma: landscapes and treatment directions},
  journal = {Molecular Oncology},
  year = {2024},
  volume = {18},
  number = {12},
  pages = {2906--2926},
  doi = {10.1002/1878-0261.13657}
}
Kostenlos starten →